Nilandron is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Nilutamide.
| Product ID | 59212-111_1c7bf50a-82ee-49ac-b1bc-35d1a2e60f36 |
| NDC | 59212-111 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nilandron |
| Generic Name | Nilutamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-07-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020169 |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Substance Name | NILUTAMIDE |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2013-07-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020169 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-01-01 |
| Marketing End Date | 2018-10-25 |
| Marketing Category | NDA |
| Application Number | NDA020169 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-07-15 |
| Ingredient | Strength |
|---|---|
| NILUTAMIDE | 150 mg/1 |
| SPL SET ID: | 5ccf0e9a-8935-4c8c-b883-b4967281eb4a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59212-111 | Nilandron | Nilutamide |
| 82454-0111 | Nilandron | Nilutamide |
| 62559-173 | Nilutamide | Nilutamide |
| 66993-212 | Nilutamide | Nilutamide |
| 82454-0212 | Nilutamide | Nilutamide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NILANDRON 74646174 1949186 Live/Registered |
CONCORDIA PHARMACEUTICALS INC. 1995-03-13 |